Article

Quantitative and dynamic analyses of G protein-coupled receptor signaling in yeast using Fus1, enhanced green fluorescence protein (EGFP), and His3 fusion protein.

Department of Molecular Science and Material Engineering, Graduate School of Science and Technology, Kobe University, Nada-ku, Japan.
Biotechnology Progress (impact factor: 2.34). 22(4):954-60. DOI:10.1021/bp0601387 pp.954-60
Source: PubMed

ABSTRACT The mechanism of G protein-coupled receptor (GPCR) signaling in yeasts is similar to that in mammalian cells. Therefore, yeasts can be used in GPCR assays, and several ligand detection systems using a pheromone signaling pathway in yeasts have been developed by employing yeasts with disrupted chromosomal genes that code for proteins producing specific effects. In this study, the construction of yeast strains that can detect ligand binding mediated by interactions between the G protein and GPCR using either fluorescence or auxotrophic selectivity is demonstrated. The strain was constructed by integrating the fusion gene of pheromone-responsive protein (FUS1), enhanced green fluorescence protein (EGFP), and auxotrophic marker protein (HIS3) into the FUS1 locus. Moreover, the influence of gene disruptions on the yeast signal transduction cascade is closely investigated with respect to both quantitative and dynamic aspects to further develop a high-throughput screening system for the GPCR assay using yeasts. Yeast strains with a disrupted SST2 gene, which is a member of the RGS (regulator of G protein signaling) family, and a disrupted FAR1 gene, which mediates cell cycle arrest in response to a pheromone, were monitored by measuring their fluorescence and growth rate. This method will be applicable to other comprehensive GPCR ligand screening methods.

0 0
 · 
0 Bookmarks
 · 
13 Views
  • Source
    Article: Cell wall trapping of autocrine peptides for human G-protein-coupled receptors on the yeast cell surface.
    [show abstract] [hide abstract]
    ABSTRACT: G-protein-coupled receptors (GPCRs) regulate a wide variety of physiological processes and are important pharmaceutical targets for drug discovery. Here, we describe a unique concept based on yeast cell-surface display technology to selectively track eligible peptides with agonistic activity for human GPCRs (Cell Wall Trapping of Autocrine Peptides (CWTrAP) strategy). In our strategy, individual recombinant yeast cells are able to report autocrine-positive activity for human GPCRs by expressing a candidate peptide fused to an anchoring motif. Following expression and activation, yeast cells trap autocrine peptides onto their cell walls. Because captured peptides are incapable of diffusion, they have no impact on surrounding yeast cells that express the target human GPCR and non-signaling peptides. Therefore, individual yeast cells can assemble the autonomous signaling complex and allow single-cell screening of a yeast population. Our strategy may be applied to identify eligible peptides with agonistic activity for target human GPCRs.
    PLoS ONE 01/2012; 7(5):e37136. · 4.09 Impact Factor

Keywords

auxotrophic marker protein
 
disrupted FAR1 gene
 
disrupted SST2 gene
 
dynamic aspects
 
fusion gene
 
G protein
 
G protein signaling
 
G protein-coupled receptor
 
gene disruptions
 
green fluorescence protein
 
high-throughput screening system
 
ligand binding
 
ligand detection systems
 
mammalian cells
 
mediates cell cycle arrest
 
pheromone signaling pathway
 
pheromone-responsive protein
 
specific effects
 
yeast signal transduction cascade
 
Yeast strains